MIRA PHARMACEUTICALS, INC. Business Finance Contracts & Agreements
12 Contracts & Agreements
- Assignment Agreements (1 contract)
- Loan Agreements (2)
- Registration Rights Agreements (1)
- Trust Agreements (1)
- Underwriting Agreements (2)
- Warrant Agreements (5)
- Promissory Note and Loan Agreement, by and between the Company and MIRALOGX, dated as of November 15, 2023 (Filed With SEC on November 20, 2023)
- Common Stock Purchase Warrant from the Company to MIRALOGX, dated November 15, 2023 (Filed With SEC on November 20, 2023)
- Representatives Warrant, dated August 7, 2023 (Filed With SEC on August 7, 2023)
- Underwriting Agreement, dated as of August 2, 2023, by and among the Company, Kingswood Investments, division of Kingswood Capital Partners, LLC and the other underwriters named... (Filed With SEC on August 7, 2023)
- Conversion Agreement, dated July 20, 2023, between MIRA Pharmaceuticals, Inc. and the Bay Shore Trust (Filed With SEC on July 21, 2023)
- Form of Representatives Warrant (Filed With SEC on July 18, 2023)
- Form of Underwriting Agreement (Filed With SEC on July 18, 2023)
- Common Stock Purchase Warrant, dated April 28, 2023, between MIRA Pharmaceuticals, Inc. and Bay Shore Trust (Filed With SEC on July 14, 2023)
- Registration Rights Agreement, dated April 28, 2023, between MIRA Pharmaceuticals, Inc. and Bay Shore Trust (Filed With SEC on June 29, 2023)
- Promissory Note and Loan Agreement, dated April 28, 2023, between MIRA Pharmaceuticals, Inc. and Bay Shore Trust (Filed With SEC on June 29, 2023)
- Confirmatory Patent Assignment and Royalty Agreement, dated November 1, 2021, between SRQ Patent Holdings II, LLC and MIRA Pharmaceuticals, Inc (Filed With SEC on June 29, 2023)
- Common Stock Purchase Warrant, dated April 28, 2023, between MIRA Pharmaceuticals, Inc. and Bay Shore Trust (Filed With SEC on June 29, 2023)
